Which has grown faster, BCRX or PGNY?

Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus PGNY at 23.84%.

Is BCRX or PGNY more profitable?

PGNY runs the higher net margin — BCRX at -40.90% versus PGNY at 6.00%.

How have BCRX and PGNY total returns compared?

Over the past 5 years, BCRX delivered -10.02% and PGNY delivered -14.83% annualized total return. Past performance doesn't predict future results.

BioCryst Pharmaceuticals, Inc. (BCRX) vs Progyny, Inc. (PGNY)

A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and Progyny, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BCRX

BioCryst Pharmaceuticals, Inc.

$2.05B

$8.06HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

PGNY

Progyny, Inc.

$2.04B

$26.02HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — BCRX vs PGNY

growth of $100 · dividends reinvested · last 7y

BCRX +246.2% (+19.4%/yr)PGNY +62.2% (+7.2%/yr)BCRX compounded faster over this window

BCRX PGNY

BCRX vs PGNY: by the numbers

•BCRX is the larger company ($2.05B vs $2.04B market cap).
•PGNY is profitable (6.00% net margin) while BCRX runs a net loss (-40.90%).
•BCRX grew revenue faster over the past five years (64.07% vs 23.84% CAGR).

Metrics side by side

Valuation

Metric	BCRX	PGNY
P/E ratio	N/A	28.28
Forward P/E	N/A	20.23
PEG ratio	N/A	4.22
P/S ratio	2.18	1.56
P/B ratio	N/A	4.50
EV / EBITDA	N/A	16.02
FCF yield	17.43%	10.69%

Profitability

Metric	BCRX	PGNY
Gross margin	97.82%	24.57%
Operating margin	38.98%	8.55%
Net margin	-40.90%	6.00%
ROE	N/A	17.35%
ROIC	-89.73%	15.47%

Growth (annualized)

Metric	BCRX	PGNY
Revenue CAGR (5Y)	64.07%	23.84%
EPS CAGR (5Y)	N/A	4.72%
FCF CAGR (5Y)	N/A	73.48%
Total return CAGR (5Y)	-10.02%	-14.83%

Frequently asked

Which has grown faster, BCRX or PGNY?: Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus PGNY at 23.84%.
Is BCRX or PGNY more profitable?: PGNY runs the higher net margin — BCRX at -40.90% versus PGNY at 6.00%.
How have BCRX and PGNY total returns compared?: Over the past 5 years, BCRX delivered -10.02% and PGNY delivered -14.83% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BCRX analysis Full PGNY analysis Interactive comparison tool

Dig into the metrics

Progyny P/E ratio BioCryst Pharmaceuticals ROE Progyny ROE BioCryst Pharmaceuticals operating margin Progyny operating margin BioCryst Pharmaceuticals revenue growth Progyny revenue growth BioCryst Pharmaceuticals free cash flow Progyny free cash flow

BioCryst Pharmaceuticals & Progyny appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.